Compile Data Set for Download or QSAR
Report error Found 615 Enz. Inhib. hit(s) with Target = '5'-AMP-activated protein kinase catalytic subunit alpha-1'
LigandPNGBDBM31085(cid_11409972 | 1-[4-[(4-ethylpiperazin-1-yl)methyl...)
Affinity DataKd:  1.40E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
LigandPNGBDBM25118(4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-...)
Affinity DataKd:  520nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
LigandPNGBDBM31088(1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-...)
Affinity DataKd:  4.50E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
LigandPNGBDBM6866(1-Acyl-1H-[1,2,4]triazole-3,5-diamine Analogue 3b ...)
Affinity DataKd:  1.70E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
LigandPNGBDBM31094(PKC-412 | cid_24202429)
Affinity DataKd:  180nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
LigandPNGBDBM31095(5-[(Z)-(5-fluoranyl-2-oxidanylidene-1H-indol-3-yli...)
Affinity DataKd:  100nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
LigandPNGBDBM31096(CHEMBL290084 | Staurosporine | cid_451705 | US2024...)
Affinity DataKd:  3.70nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
LigandPNGBDBM4814(SUNITINIB MALATE | CHEMBL535 | N-[2-(diethylamino)...)
Affinity DataKd:  19nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
LigandPNGBDBM13534(VX680 | N-[4-[[4-(4-methylpiperazino)-6-[(5-methyl...)
Affinity DataKd:  1.10E+3nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2011
Entry Details
PCBioAssay
LigandPNGBDBM192505(US9187477, 1)
Affinity DataEC50:  1.20nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192506(US9187477, 2)
Affinity DataEC50:  32nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192507(US9187477, 3)
Affinity DataEC50:  108nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192508(US9187477, 16 | US9187477, 4)
Affinity DataEC50:  12nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192509(US9187477, 5)
Affinity DataEC50:  119nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192510(US9187477, 6)
Affinity DataEC50:  6nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192511(US9187477, 7)
Affinity DataEC50:  468nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192512(US9187477, 8)
Affinity DataEC50:  339nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192513(US9187477, 9)
Affinity DataEC50:  17nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192514(US9187477, 10)
Affinity DataEC50:  26nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192515(US9187477, 11)
Affinity DataEC50:  35nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192516(US9187477, 12)
Affinity DataEC50:  1.31E+3nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192517(US9187477, 13)
Affinity DataEC50:  2.04E+3nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192518(US9187477, 14)
Affinity DataEC50:  578nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192519(US9187477, 15)
Affinity DataEC50:  133nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM192508(US9187477, 16 | US9187477, 4)
Affinity DataEC50:  290nMpH: 7.0Assay Description:In the 384-well plates 1.25 ul of test compound in assay buffer (20 mM HEPES pH 7.0, 0.025% BSA, 15 mM MgCl2, 0.01% Brij) was mixed with 1.25 ul of A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/12/2016
Entry Details
Go to US Patent

LigandPNGBDBM240765(US9422312, 1)
Affinity DataEC50:  26nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240766(US9422312, 2)
Affinity DataEC50:  20nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240767(US9422312, 3)
Affinity DataEC50:  94nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240768(US9422312, 4)
Affinity DataEC50:  52nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240769(US9422312, 5)
Affinity DataEC50:  15nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240770(US9422312, 6)
Affinity DataEC50:  54nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240771(US9422312, 7)
Affinity DataEC50:  37nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240772(US9422312, 8)
Affinity DataEC50:  61nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240773(US9422312, 9)
Affinity DataEC50:  89nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240774(US9422312, 10)
Affinity DataEC50:  17nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240775(US9422312, 11)
Affinity DataEC50:  62nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240776(US9422312, 12)
Affinity DataEC50:  2nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240777(US9422312, 13)
Affinity DataEC50:  30nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240778(US9422312, 14)
Affinity DataEC50:  52nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240779(US9422312, 15)
Affinity DataEC50:  90nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240780(US9422312, 16)
Affinity DataEC50:  48nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240785(US9422312, 17)
Affinity DataEC50:  202nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240781(US9422312, 18)
Affinity DataEC50:  67nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240782(US9422312, 19)
Affinity DataEC50:  138nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240783(US9422312, 20)
Affinity DataEC50:  82nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240784(US9422312, 21)
Affinity DataEC50:  2.90E+3nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM237920(US9394285, 1)
Affinity DataEC50:  4.20nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/17/2017
Entry Details
Go to US Patent

LigandPNGBDBM237921(US9394285, 2)
Affinity DataEC50:  64.7nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/17/2017
Entry Details
Go to US Patent

LigandPNGBDBM237922(US9394285, 3)
Affinity DataEC50:  459nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/17/2017
Entry Details
Go to US Patent

LigandPNGBDBM237923(US9394285, 4)
Affinity DataEC50:  71nMpH: 7.5 T: 2°CAssay Description:The biochemical EC50 (half-maximal concentration required for full activation) of compounds for the activation of AMPK was evaluated by 33P-based ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/17/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 615 total ) | Next | Last >>
Jump to: